Updated:
Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc. is based in London; the profile covers headquarters, registration, AUM band and key contacts for private-markets fundraising.
Overview
General information
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Additional offices
San Francisco · Cambridge · Boston · Waltham · Washington · Munich · Stockholm · Wilmington · Chicago
Sector focus
Frequently asked questions
What therapeutic areas does Livzon target for drug development?
Livzon targets five core therapeutic areas: digestive health, psychiatric/neurological disorders, assisted reproduction, anti-infectives, and oncology. Its portfolio includes branded generics, innovative drugs, and APIs.
What is Livzon's AI/ML strategy in drug development?
Livzon applies AI and machine learning to formulation design (e.g., microsphere long-acting injections) and clinical trial optimization. Recent press releases highlight AI-driven clinical trial design for JP-1366 and exploration of OpenClaw technology for AI-based R&D (per company, April 2026).
Where are Livzon's global offices located?
Livzon lists corporate headquarters in London, with additional offices in San Francisco, Cambridge, Boston, Waltham, Washington, Munich, Stockholm, Wilmington, and Chicago (per Altss research record). Its primary R&D and manufacturing are in China.
What is Livzon's microsphere technology platform?
Livzon's microsphere platform develops long-acting injectable formulations for psychiatric and reproductive health therapies. Pipeline examples include aripiprazole microsphere (injectable) and brexpiprazole microsphere for schizophrenia, both in clinical stages (per company filings, 2025–2026).
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: